NCT06787937

Brief Summary

The goal of this clinical trial is to learn how a messaging campaign about reduced nicotine cigarettes and policy, combined with the use of very low nicotine cigarettes (VLNCs), affects smoking behavior and attitudes among adult smokers. The study also aims to assess the efficacy of the messages in different populations, including smokers with past-month serious psychological distress (SPD), low socioeconomic status (SES), and those in neither category. The primary hypothesis is: exposure to messages in combination with VLNC use will lead to less cigarettes use compared to VLNCs without messages. Researchers will compare: The effects of receiving VLNCs with messages (treatment group) to receiving VLNCs without messages (control group). Participants will: Complete a baseline survey and be randomly assigned to one of two groups: treatment (VLNCs + messages) or control (VLNCs only). Attend weekly study visits for surveys, breath samples, and receive supply of VLNCs , either with or without the messaging campaign. Complete brief daily surveys through text messages.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,230

participants targeted

Target at P75+ for not_applicable

Timeline
33mo left

Started Sep 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress19%
Sep 2025Jan 2029

First Submitted

Initial submission to the registry

December 25, 2024

Completed
28 days until next milestone

First Posted

Study publicly available on registry

January 22, 2025

Completed
8 months until next milestone

Study Start

First participant enrolled

September 11, 2025

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2029

Last Updated

October 29, 2025

Status Verified

October 1, 2025

Enrollment Period

3.4 years

First QC Date

December 25, 2024

Last Update Submit

October 28, 2025

Conditions

Keywords

smokinghealth communicationvery low nicotine cigarettes

Outcome Measures

Primary Outcomes (1)

  • Cigarettes per day

    Number of cigarettes smoked per day (study and non-study cigarettes). * Averaged number of cigarettes smoked based on 7 days' daily logs submitted through text-based survey during the last week of the trial. * Response: integer indicating number per day.

    Week 4 of the trial (post randomization)

Secondary Outcomes (7)

  • Use of other tobacco products

    Week 4 of the trial (post randomization)

  • Use of cessation medications

    Week 4 of the trial (post randomization)

  • Forgoing cigarettes

    Through study completion, up to 4 weeks

  • Making a quit attempt

    Through study completion, up to 4 weeks

  • Perceived risk of smoking VLNCs

    Week 4 of the trial (post randomization)

  • +2 more secondary outcomes

Study Arms (2)

VLNC with message campaign

EXPERIMENTAL

Participants in this arm will receive VLNCs during weekly visits and be exposed to messaging about VLNCs and reduced nicotine policy through multiple formats, including inserts placed in cigarette packs, printed advertisements, and videos presented during weekly visits.

Behavioral: VLNC messages

VLNC only

OTHER

Participants in this arm will receive VLNCs during weekly visits but will not receive any messaging related to cigarettes or reduced nicotine policy. Instead, they will only be exposed to control messages, such as advertisements for bottled water, during weekly visits.

Behavioral: Control message

Interventions

VLNC messagesBEHAVIORAL

Participants will be exposed to messaging about VLNCs and reduced nicotine policy through multiple formats, including inserts placed in cigarette packs, printed advertisements, and video materials presented during their weekly visits.

VLNC with message campaign
Control messageBEHAVIORAL

Participants will be exposed to control messages, such as advertisements for bottled water, during their weekly visits.

VLNC only

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 21+ years
  • Current smoker (self-report as having smoked 100 cigarettes in their lifetime and currently smoking on 27+ days out of past 30, expired breath carbon monoxide \[CO\] ≥6ppm to assess regular smoking)
  • Can speak, read, and write in English
  • Available for period of study
  • Willing to try novel research cigarettes

You may not qualify if:

  • Pregnancy or lactation
  • Member of the same household as a study subject
  • Unwilling to use research cigarettes as part of the trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Georgia State university

Atlanta, Georgia, 30303, United States

RECRUITING

Emory University

Atlanta, Georgia, 30322, United States

RECRUITING

Related Publications (1)

  • Pei D, Juris A, Nkansah P, Thrasher JF, Giordano NA, Henderson KC, Spears CA, Ashley DL, Mallory VC, Adeniji FP, Foster JD, Ni W, Kodriati N, Ogunnaike A, Pechacek TF, Kirpich A, Popova L. Nicotine Intervention and Communication for Empowering Reduction (NICER): study protocol for a randomized controlled trial among priority populations of people who smoke. Trials. 2025 Nov 17;26(1):514. doi: 10.1186/s13063-025-09216-8.

MeSH Terms

Conditions

Smoking

Condition Hierarchy (Ancestors)

Behavior

Central Study Contacts

Lyudmila Popova, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 25, 2024

First Posted

January 22, 2025

Study Start

September 11, 2025

Primary Completion (Estimated)

January 31, 2029

Study Completion (Estimated)

January 31, 2029

Last Updated

October 29, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations